J. Wrin

发表

Can we accurately report PTEN status in advanced colorectal cancer?

T. Price, N. Tebbutt, A. Ruszkiewicz, 2014, BMC Cancer.

Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab*

R. Simes, T. Price, N. Tebbutt, 2013, Cancer medicine.

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

T. Price, N. Tebbutt, Chee Khoon Lee, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis

T. Price, N. Tebbutt, J. Hardingham, 2012 .

Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells.

N. Voelcker, T. Price, B. Thierry, 2014, ACS applied materials & interfaces.

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer

V. Gebski, J. Simes, D. Cunningham, 2015, British Journal of Cancer.

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

Y. Tomita, T. Price, J. Hardingham, 2017, Clinical and Translational Oncology.

Identification of a cell surface protein with a role in stimulating human keratinocyte proliferation, expressed during development and carcinogenesis.

S. Olsen, J. Danks, J. Furze, 1997, The Journal of investigative dermatology.

Correlation of PI3KCA and extended RAS gene mutation status with outcomes from the phase III AGITG MAX involving capecitabine (C) alone or in combination with bevacizumab (B) with or without mitomycin C (M) in advanced colorectal cancer (CRC).

V. Gebski, J. Simes, D. Cunningham, 2014 .

Renaturation and Purification of Biologically Active Recombinant Human Macrophage Colony-Stimulating Factor Expressed in E. Coli

E. Kawasaki, R. Halenbeck, Ernest Kawasaki, 1989, Bio/Technology.

Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro

A. Evdokiou, T. Price, J. Hardingham, 2016, Journal of Experimental & Clinical Cancer Research.

Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age

T. Price, W. Raymond, W. Ingman, 2020, Breast Cancer Research.

Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk

S. Barry, W. Ingman, J. Wrin, 2016, Front. Oncol..

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer

D. Cunningham, T. Price, N. Tebbutt, 2014, International journal of cancer.

Measurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay.

G L Francis, J. Wallace, S. E. Knowles, 1998, The Journal of endocrinology.

Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age

T. Price, W. Raymond, W. Ingman, 2020, Breast Cancer Research.

High-affinity monoclonal antibodies against P-glycoprotein.

J. Wrin, D. Ring, J. Reeder, 1995, Clinical Immunology and Immunopathology.

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

T. Price, N. Tebbutt, C. Murone, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.